ARTICLE | Emerging Company Profile
MD Pharma AB: Dialing down autophagy
Sweden's MD Pharma targeting autophagy in congenital muscular dystrophy
January 28, 2013 8:00 AM UTC
With no approved drugs for congenital muscular dystrophy, patients often die in their teens. MD Pharma AB is developing autophagy inhibitors that could extend and improve quality of life for a subgroup of patients.
The subtypes of congenital muscular dystrophy (MD) are defined by the genetic mutations and defective proteins that lead to muscle loss...